Vivus, Why the Slide? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus, Why the Slide?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tunica Albuginea who wrote (2145)	6/21/1997 2:33:00 PM
From: Richard Singer	of 3991

T.A. Thanks for your response to my questions. With all due respect, I wasn't looking for your opinions re these issues, but rather new published data by those who have a track to David Y. I hoped the Cabot Letter might shed some light, but apparently nothing new has been added. With the split out of the way next week, the focus is on Q2 earnings and revenues. The gross margin in the 1st quarter was 71%, but is not likely to be repeated, due primarily to increased inventory costs. I don't see how product sales numbers can be much off from what has been projected, and I'll be real happy with those numbers. Richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next